Key result
Hormone-replacement therapy vascular effects vary by age, differing in early versus late menopause.
Answers are grounded in this paper and cite their sources.
For the past decade, women and health care providers have faced confusing information about the effects of hormone-replacement therapy, or HRT, on heart disease. Important practical questions have remained unresolved: Who can safely receive hormone-replacement therapy? Who is at increased risk from hormone-replacement therapy? Might any women benefit from hormone-replacement therapy for reasons other than relief from menopausal symptoms?Now, some clarity about hormone-replacement therapy and heart disease is emerging. New research supports the concept that hormone-replacement therapy has different effects on blood vessels in younger menopausal women (50 to 59 years old) than in women long after menopause, underscoring . . .
No takes yet. Share an insight, caveat, or question.
Mendelsohn et al. (2007) conducted an editorial in Heart disease. Hormone-replacement therapy was evaluated. Hormone-replacement therapy has different effects on blood vessels in younger menopausal women aged 50 to 59 years compared to women long after menopause.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: